1. Department of Oncology; Massachusetts General Hospital; Boston Massachusetts
2. Dana-Farber Cancer Institute, Center for Outcomes and Policy Research; Harvard Medical School; Boston Massachusetts
3. Department of Hematological Malignancies; Dana-Farber Cancer Institute; Boston Massachusetts
4. Division of Hematologic Malignancies and Cellular Therapy; Duke University School of Medicine; Durham North Carolina